Katty Wan

1.1k total citations
15 papers, 887 citations indexed

About

Katty Wan is a scholar working on Molecular Biology, Spectroscopy and Immunology. According to data from OpenAlex, Katty Wan has authored 15 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Spectroscopy and 3 papers in Immunology. Recurrent topics in Katty Wan's work include DNA and Nucleic Acid Chemistry (7 papers), Mass Spectrometry Techniques and Applications (7 papers) and Biosimilars and Bioanalytical Methods (3 papers). Katty Wan is often cited by papers focused on DNA and Nucleic Acid Chemistry (7 papers), Mass Spectrometry Techniques and Applications (7 papers) and Biosimilars and Bioanalytical Methods (3 papers). Katty Wan collaborates with scholars based in United States, Japan and Germany. Katty Wan's co-authors include Michael L. Gross, Toshimichi Shibue, Ilan Vidavsky, Franz Hillenkamp, Julia Christina Gross, John‐Stephen Taylor, Ragulan Ramanathan, Hong Liu, James W. Sawicki and Vaidyanathan Srirajan and has published in prestigious journals such as Journal of the American Chemical Society, Clinical Pharmacology & Therapeutics and British Journal of Clinical Pharmacology.

In The Last Decade

Katty Wan

15 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katty Wan United States 11 541 479 67 51 50 15 887
David M. Bunk United States 23 590 1.1× 466 1.0× 89 1.3× 33 0.6× 23 0.5× 52 1.7k
Thomas R. Covey Canada 8 364 0.7× 497 1.0× 65 1.0× 73 1.4× 74 1.5× 9 776
Anoop Mayampurath United States 22 943 1.7× 634 1.3× 73 1.1× 28 0.5× 21 0.4× 84 1.6k
Michael J. Greig United States 20 995 1.8× 666 1.4× 212 3.2× 140 2.7× 32 0.6× 30 1.5k
K. Olaf Boernsen Switzerland 10 175 0.3× 170 0.4× 50 0.7× 39 0.8× 30 0.6× 16 454
Jin Wu China 17 569 1.1× 484 1.0× 63 0.9× 49 1.0× 78 1.6× 58 1.1k
Jane D. Roberts United States 16 201 0.4× 318 0.7× 45 0.7× 79 1.5× 21 0.4× 23 745
Catherine C. Fenselau United States 18 355 0.7× 529 1.1× 102 1.5× 93 1.8× 74 1.5× 31 978
Xinghua Guo China 17 196 0.4× 315 0.7× 97 1.4× 69 1.4× 93 1.9× 47 794
Philip M. Remes United States 11 702 1.3× 779 1.6× 71 1.1× 28 0.5× 71 1.4× 21 1.1k

Countries citing papers authored by Katty Wan

Since Specialization
Citations

This map shows the geographic impact of Katty Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katty Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katty Wan more than expected).

Fields of papers citing papers by Katty Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katty Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katty Wan. The network helps show where Katty Wan may publish in the future.

Co-authorship network of co-authors of Katty Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Katty Wan. A scholar is included among the top collaborators of Katty Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katty Wan. Katty Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wan, Katty, et al.. (2024). Patient-centric microsampling for abrocitinib pharmacokinetics: multiple-analytes assay bridging using Tasso device. Bioanalysis. 16(15). 1–10. 4 indexed citations
2.
Cox, Donna S., et al.. (2023). Effects of nirmatrelvir/ritonavir on midazolam and dabigatran pharmacokinetics in healthy participants. British Journal of Clinical Pharmacology. 89(11). 3352–3363. 11 indexed citations
3.
Wan, Katty, Bharat Damle, Haihong Shi, et al.. (2023). Patient Centric Microsampling to Support Paxlovid Clinical Development: Bridging and Implementation. Clinical Pharmacology & Therapeutics. 115(1). 42–51. 11 indexed citations
4.
Liu, Hong, Yanbin Lao, Katty Wan, et al.. (2016). Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites. Drug Metabolism and Disposition. 45(3). 294–305. 77 indexed citations
5.
Wan, Katty, et al.. (2012). Toxicokinetic Evaluation of Atrasentan in Mice Utilizing Serial Microsampling: Validation And Sample Analysis in Glp Study. Bioanalysis. 4(11). 1351–1361. 5 indexed citations
6.
Wan, Katty, Matthew J. Rieser, & Tawakol A. El‐Shourbagy. (2010). Quantitative Determination of ABT-925 in Human Plasma by On-Line SPE and LC-MS/MS: Validation and Sample Analysis in Phase II Studies. Pharmaceutics. 2(2). 171–181. 2 indexed citations
7.
Zhu, Tong, Walid M. Awni, Balakrishna Hosmane, et al.. (2008). ABT‐335, the Choline Salt of Fenofibric Acid, Does Not Have a Clinically Significant Pharmacokinetic Interaction With Rosuvastatin in Humans. The Journal of Clinical Pharmacology. 49(1). 63–71. 26 indexed citations
8.
Wan, Katty, Ilan Vidavsky, & Michael L. Gross. (2002). Comparing similar spectra: From similarity index to spectral contrast angle. Journal of the American Society for Mass Spectrometry. 13(1). 85–88. 188 indexed citations
9.
Gross, Julia Christina, Franz Hillenkamp, Katty Wan, & Michael L. Gross. (2001). Metastable decay of negatively charged oligodeoxynucleotides analyzed with ultraviolet matrix-assisted laser desorption/ionization post-source decay and deuterium exchange. Journal of the American Society for Mass Spectrometry. 12(2). 180–192. 42 indexed citations
10.
Wan, Katty, Julia Christina Gross, Franz Hillenkamp, & Michael L. Gross. (2001). Fragmentation mechanisms of oligodeoxynucleotides studied by H/D exchange and electrospray ionization tandem mass spectrometry. Journal of the American Society for Mass Spectrometry. 12(2). 193–205. 83 indexed citations
11.
Wan, Katty & Michael L. Gross. (2001). Fragmentation mechanisms of oligodeoxynucleotides: Effects of replacing phosphates with methylphosphonates and thymines with other bases in T-rich sequences. Journal of the American Society for Mass Spectrometry. 12(5). 580–589. 53 indexed citations
12.
Shibue, Toshimichi, Katty Wan, & Michael L. Gross. (2000). A Study of Non-Covalent Interaction between DNA-Binding Drugs and Double-Stranded Oligodeoxynucleotides by ESI Ion Trap Mass Spectrometry.. Journal of the Mass Spectrometry Society of Japan. 48(3). 221–227. 4 indexed citations
13.
Wan, Katty, Michael L. Gross, & Toshimichi Shibue. (2000). Gas-phase stability of double-stranded oligodeoxynucleotides and their noncovalent complexes with DNA-binding drugs as revealed by collisional activation in an ion trap. Journal of the American Society for Mass Spectrometry. 11(5). 450–457. 134 indexed citations
14.
Wan, Katty, Toshimichi Shibue, & Michael L. Gross. (1999). Non-Covalent Complexes between DNA-Binding Drugs and Double-Stranded Oligodeoxynucleotides:  A Study by ESI Ion-Trap Mass Spectrometry. Journal of the American Chemical Society. 122(2). 300–307. 158 indexed citations
15.
Wan, Katty, et al.. (1998). Structure and fragmentation mechanisms of isomeric T-rich oligodeoxynucleotides: A comparison of four tandem mass spectrometric methods. Journal of the American Society for Mass Spectrometry. 9(7). 683–691. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026